IRIS
SEMERARO, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.713
EU - Europa 384
AS - Asia 101
SA - Sud America 2
Totale 2.200
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.713
DE - Germania 107
CN - Cina 92
SE - Svezia 78
IT - Italia 65
UA - Ucraina 29
FR - Francia 27
FI - Finlandia 22
GB - Regno Unito 18
BE - Belgio 15
IE - Irlanda 11
CZ - Repubblica Ceca 4
IN - India 3
NL - Olanda 3
SG - Singapore 2
VN - Vietnam 2
BR - Brasile 1
CL - Cile 1
ES - Italia 1
IL - Israele 1
IS - Islanda 1
LU - Lussemburgo 1
PK - Pakistan 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.200
Salva come PNG Salva come JPEG
Città #
Fairfield 288
Woodbridge 192
Houston 160
Chandler 147
Ashburn 139
Seattle 114
Cambridge 97
Wilmington 88
Jacksonville 78
Ann Arbor 70
Nyköping 70
Bari 40
Roxbury 29
Lawrence 27
Beijing 18
Nanjing 18
Inglewood 17
Brussels 15
Des Moines 14
Grafing 14
Princeton 13
Strasbourg 13
Dublin 11
San Diego 11
New York 10
Hebei 8
Brooklyn 7
Frankfurt am Main 7
Nanchang 7
Boardman 6
Paris 6
Tianjin 6
Changsha 5
London 5
Shenyang 5
Brno 4
Redwood City 4
Bethlehem 3
Dearborn 3
Jiaxing 3
Munich 3
Pune 3
Chengdu 2
Dong Ket 2
Kunming 2
San Mateo 2
Singapore 2
Zhengzhou 2
Altamura 1
Amsterdam 1
Augusta 1
Barletta 1
Bratislava 1
Changchun 1
Chicago 1
Chongqing 1
Cutrofiano 1
Francavilla Fontana 1
Guangzhou 1
Hefei 1
Heze 1
Hounslow 1
Jinan 1
Keflavik 1
Kilburn 1
Lahore 1
Lorca 1
Luxembourg 1
Mantova 1
Marseille 1
Mascalucia 1
Napoli 1
Prescot 1
Quanzhou 1
San Francisco 1
San Jose 1
Shanghai 1
São Paulo 1
Tampa 1
Tel Aviv 1
Washington 1
Totale 1.823
Salva come PNG Salva come JPEG
Nome #
Platelet drop and fibrinolytic shutdown in patients with sepsis 122
Histones differentially modulate the anticoagulant and profibrinolytic activities of heparin, heparin derivatives and dabigatran. 119
Factor IX-Padua enhances the fibrinolytic resistance of plasma clots 115
Dabigatran but not rivaroxaban or apixaban treatment decreases fibrinolytic resistance in patients with atrial fibrillation 108
Coagulopathy of Acute Sepsis 104
Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors 104
Grape intake reduces thrombin generation and enhances plasma fibrinolysis. Potential role of circulating procoagulant microparticles 100
Profibrinolytic activity of the direct thrombin inhibitor melagatran and unfractionated heparin in platelet-poor and platelet-rich clots 97
Platelets and fibrinolysis 93
Sepsis, thrombosis and organ dysfunction 92
Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor 84
Hyperprothrombinemia-induced APC resistance: differential influence on fibrin formation and fibrinolysis 82
Endothelial cells in the bone marrow of patients with multiple myeloma 78
Low D-dimer levels in sepsis: Good or bad? 78
Mild hyperhomocysteinemia is associated with increased TAFI levels and reduced plasma fibrinolytic potential 77
FVIII/VWF complex displays a greater pro-hemostatic activity than FVIII preparations devoid of VWF. Study in plasma and cell-based models 74
Gene expression signature induced by grape intake in healthy subjects reveals wide-spread beneficial effects on peripheral blood mononuclear cells 73
Sepsis-associated disseminated intravascular coagulation and thromboembolic disease. 67
The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood 64
Monoclonal antibodies targeting the antifibrinolytic activity of activated TAFI but not the anti-inflammatory activity on osteopontin and C5a 61
TISSUE FACTOR-EXPRESSING MONOCYTES INHIBIT FIBRINOLYSIS THROUGH A TAFI-MEDIATED MECHANISM, AND MAKE CLOTS RESISTANT TO HEPARINS 61
D-dimer corrected for thrombin and plasmin generation is a strong predictor of mortality in patients with sepsis 61
Evidence that fibrynolitic changes in paediatric obesity translate in a hypofibrinolytic state. Relative contribution of TAFI and PAI-1 53
Extracellular histones promote fibrinolysis by single-chain urokinase-type plasminogen activator in a factor seven activating protease-dependent way 50
Coagulation-fibrinolysis changes during off-pump bypass: effect of two heparin doses 48
A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma 47
Diversi fattori contribuiscono alla ipofibrinolisi nei bambini obesi 41
Angiogenic endothelial cells within the bone marrow of multiple myeloma. A phenotypic and functional assessment 35
The contribution of anti-Xa and anti-IIa activities to the profibrinolytic activity of LMWHs 24
null 23
Randomised trial of chronic supplementation with a nutraceutical mixture in subjects with non-alcoholic fatty liver disease 22
Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy 1
Thrombin activatable fibrinolysis inhibitor pathway alterations correlate with bleeding phenotype in patients with severe hemophilia A 1
Totale 2.259
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.934
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020599 81 26 9 58 72 39 61 69 88 29 45 22
2020/2021369 22 39 19 20 53 27 28 42 41 49 16 13
2021/2022254 12 44 3 5 3 13 21 14 12 22 45 60
2022/2023387 55 50 23 34 30 40 6 54 80 1 10 4
2023/2024108 12 22 2 13 8 16 2 10 0 2 6 15
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 2.259